210 related articles for article (PubMed ID: 18766180)
21. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
22. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
Furrer D; Grégoire J; Turcotte S; Plante M; Bachvarov D; Trudel D; Têtu B; Douville P; Bairati I
PLoS One; 2019; 14(6):e0218621. PubMed ID: 31220149
[TBL] [Abstract][Full Text] [Related]
23. Serum human kallikrein 7 represents a new marker for cervical cancer.
Li W; Zhao Y; Ren L; Wu X
Med Oncol; 2014 Oct; 31(10):208. PubMed ID: 25182706
[TBL] [Abstract][Full Text] [Related]
24. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
Huo J; Hu J; Liu G; Cui Y; Ju Y
Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
Lee YJ; Lee IH; Kim YJ; Chung YS; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
PLoS One; 2018; 13(9):e0203366. PubMed ID: 30188915
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based Chemotherapy.
Miao Y; Li S; Yan Q; Li B; Feng Y
Oncol Res Treat; 2016; 39(11):712-719. PubMed ID: 27855385
[TBL] [Abstract][Full Text] [Related]
28. Nidogen-1: a candidate biomarker for ovarian serous cancer.
Li L; Zhang Y; Li N; Feng L; Yao H; Zhang R; Li B; Li X; Han N; Gao Y; Xiao T; Wu L
Jpn J Clin Oncol; 2015 Feb; 45(2):176-82. PubMed ID: 25378651
[TBL] [Abstract][Full Text] [Related]
29. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
[TBL] [Abstract][Full Text] [Related]
30. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
[TBL] [Abstract][Full Text] [Related]
31. Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer.
Le T; Faught W; Hopkins L; Fung-Kee-Fung M
J Obstet Gynaecol Can; 2008 Aug; 30(8):665-670. PubMed ID: 18786288
[TBL] [Abstract][Full Text] [Related]
32. Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response.
Bandiera E; Zanotti L; Bignotti E; Romani C; Tassi R; Todeschini P; Tognon G; Ragnoli M; Santin AD; Gion M; Pecorelli S; Ravaggi A
Int J Gynecol Cancer; 2009 Aug; 19(6):1015-21. PubMed ID: 19820362
[TBL] [Abstract][Full Text] [Related]
33. Serum proteomic patterns for ovarian cancer monitoring.
Helleman J; van der Vlies D; Jansen MP; Luider TM; van der Burg ME; Stoter G; Berns EM
Int J Gynecol Cancer; 2008; 18(5):985-95. PubMed ID: 18028381
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.
Dorn J; Gkazepis A; Kotzsch M; Kremer M; Propping C; Mayer K; Mengele K; Diamandis EP; Kiechle M; Magdolen V; Schmitt M
Biol Chem; 2014 Jan; 395(1):95-107. PubMed ID: 23999494
[TBL] [Abstract][Full Text] [Related]
35. Bead-based ELISA for validation of ovarian cancer early detection markers.
Scholler N; Crawford M; Sato A; Drescher CW; O'Briant KC; Kiviat N; Anderson GL; Urban N
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2117-24. PubMed ID: 16609024
[TBL] [Abstract][Full Text] [Related]
36. Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer.
Link T; Passek S; Wimberger P; Frank K; Vassileva YD; Kramer M; Kuhlmann JD
Int J Cancer; 2020 May; 146(9):2608-2618. PubMed ID: 31509615
[TBL] [Abstract][Full Text] [Related]
37. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP
Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730
[TBL] [Abstract][Full Text] [Related]
38. Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian cancer: brief report.
Skaznik-Wikiel ME; Sukumvanich P; Beriwal S; Zorn KK; Kelley JL; Richard SD; Krivak TC
Int J Gynecol Cancer; 2011 Aug; 21(6):1013-7. PubMed ID: 21792011
[TBL] [Abstract][Full Text] [Related]
39. KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
El Sherbini MA; Mansour AA; Sallam MM; Shaban EA; Shehab ElDin ZA; El-Shalakany AH
J Ovarian Res; 2018 Apr; 11(1):32. PubMed ID: 29690914
[TBL] [Abstract][Full Text] [Related]
40. Serum microRNA-145 as a novel biomarker in human ovarian cancer.
Liang H; Jiang Z; Xie G; Lu Y
Tumour Biol; 2015 Jul; 36(7):5305-13. PubMed ID: 25722112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
